dr. Sarah Bonte
- Work address
-
C. Heymanslaan 10, ingang 12 - verdieping 6
9000 Gent - SarahM.Bonte@UGent.be
- ORCID iD
-
0000-0002-0637-4893
Show
Sort by
-
- Journal Article
- A1
- open access
Small-scale manufacturing of neoantigen-encoding messenger RNA for early-phase clinical trials
-
- Journal Article
- A1
- open access
In vitro OP9-DL1 co-culture and subsequent maturation in the presence of IL-21 generates tumor antigen-specific T cells with a favorable less-differentiated phenotype and enhanced functionality
-
TCR-based T cell immunotherapy for AML : multidimensional aids in optimizing treatment and patient identification
(2021) -
- Journal Article
- A1
- open access
Human thymic CD10+ PD-1+ intraepithelial lymphocyte precursors acquire interleukin-15 responsiveness at the CD1a– CD95+ CD28– CCR7– developmental stage
-
- Journal Article
- A1
- open access
Rapid and effective generation of nanobody based CARs using PCR and Gibson Assembly
-
- Journal Article
- A1
- open access
T-cells with a single tumor antigen-specific T-cell receptor can be generated in vitro from clinically relevant stem cell sources
-
- Journal Article
- A1
- open access
Nanobody based dual specific CARs
-
- Conference Paper
- C3
- open access
In vitro generation of tumor antigen-specific T cells from patient and healthy donor stem cells
-
The checkpoint for agonist selection precedes conventional selection in human thymus
-
- Journal Article
- A1
- open access
Antigen receptor-redirected T cells derived from hematopoietic precursor cells lack expression of the endogenous TCR/CD3 receptor and exhibit specific antitumor capacities